Autoimmunity and environmental factors in the pathogenesis of primary biliary cirrhosis

References

• Tsuji K, Watanabe Y, Van De Water J, Nakanishi T, Kajiyama G, Parikh-Patel A, et al. Familial primary biliary cirrhosis in Hiroshima. J Autoimmun 1999;13:171–8.
   Google Scholar
• Jones DE, Watt FE, Metcalf JV, Bassendine MF, James OF. Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol 1999;30:402–7.
   Google Scholar
• Triger DR. Primary biliary cirrhosis: an epidemiological study. BMJ 1980;281:772–5.
   PubMed Web of Science ®Google Scholar
• Uibo R, Salupere V. The epidemiology of primary biliary cirrhosis: immunological problems. Hepatogastroenterology 1999;46:3048–52.
   Google Scholar
• Watson RG, Angus PW, Dewar M, Goss B, Sewell RB, Smallwood RA. Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver Group. Gut 1995; 36: 927–30.
   Google Scholar
• Triger DR. Primary biliary cirrhosis: is there an environ-mental contribution? J Gastroenterol Hepatol 1991;6:568–9.
   Google Scholar
• Prince MI, Chetwynd A, Diggle P, Jarner M, Metcalf JV, James OF. The geographical distribution of primary biliary cirrhosis in a well defined cohort. Hepatology 200104:1083–8.
   Google Scholar
• Sutton I, Neuberger J. Primary biliary cirrhosis: seeking the silent partner of autoimmunity. Gut 2002;50:743–6.
   PubMed Web of Science ®Google Scholar
• Coppel RL, Gershwin ME. Primary biliary cirrhosis: The molecule and the mimic. Immunol Rev 1995;144:17–49.
   PubMed Web of Science ®Google Scholar
• Gershwin ME, Ansari AA, Mackay IR, Nakanuma Y, Nishio A, Rowley MJ, et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells [In Process Citation]. Immunol Rev 2000;174:210–25.
   PubMed Web of Science ®Google Scholar
• Palmer JM, Kirby JA, Jones DE. The immunology of primary biliary cirrhosis: the end of the beginning? Clin Exp Immunol 2002;129:91–7.
   Google Scholar
• Mackay CR. Homing of naive, memory and effector lympho-cytes. Curr Opin Immunol 1993;5:423–7.
   PubMed Web of Science ®Google Scholar
• Quill H. Anergy as a mechanism of peripheral T cell tolerance. J Immunol 1996;156:1325–7.
   Google Scholar
• Bretscher P, Cohn M. A theory of self non-self discrimination. Science 1970;169:1042–9.
   PubMed Web of Science ®Google Scholar
• Lafferty KJ, Cunningham A J. A new analysis of allogeneic interactions. Australian Journal of Experimental Biology Medical Science 1975;53:27–42.
   PubMedGoogle Scholar
• Martin E, O'Sullivan B, Low P, Thomas R. Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity 2003;18:155–67.
   PubMed Web of Science ®Google Scholar
• Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003;21:685–711.
   PubMed Web of Science ®Google Scholar
• Kita H, Mackay IR, Van De Water J, Gershwin ME. The lymphoid liver: considerations on pathways to autoimmune injury. Gastroenterology 2001;120:1485–501.
   Google Scholar
• Coppel RL, McNeilage LJ, Surh CD, Van de Water J, Spithill TW, Whittingham S, et al. Primary structure of the human M2 initochondrial autoantigen of primary biliary cirrhosis: di-hydrolipoamide acetyltransferase. Proc Natl Acad Sci USA 1988;85: 7317–21.
   Google Scholar
• Van de Water J, Ansari AA, Surh CD, Coppel R, Roche T, Bonkovsky H, et al. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis. J Immunol 1991;146:89–94.
   PubMed Web of Science ®Google Scholar
• Van de Water J, Ansari A, Prindiville T, Coppel R, Ricalton N, Kotzin BL, et al. Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate de-hydrogenase complex in primary biliary cirrhosis. J Exp Med 1995;181:723–33.
   PubMed Web of Science ®Google Scholar
• Shimoda S, Nakamura M, Ishibashi H, Hayashida K, Niho Y. HLA DRB4 0101-restricted immunodominant T cell auto-epitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human auto-immune diseases. J Exp Med 1995;181: 1835–45.
   Google Scholar
• Shimoda S, Van de Water J, Ansari A, Nakamura M, Ishibashi H, Coppel RL, et al. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest 1998; 102:1831–40.
   PubMed Web of Science ®Google Scholar
• Kita H, Lian ZX, Van De Water J, He XS, Matsumura S, Kaplan M, et al. Identification of HLA-A2-restricted CD8(+) Cytotoxic T Cell Responses in Primary Biliary Cirrhosis: T Cell Activation Is Augmented by Immune Complexes Cross-Presented by Dendritic Cells. J Exp Med 2002;195: 113–23.
   Google Scholar
• Kita H, Matsumura S, He XS, Ansari AA, Lian ZX, Van de Water J, et al. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest 2002;109: 1231–40.
   Google Scholar
• Warnock MG, Goodacre JA. Cryptic T-cell epitopes and their role in the pathogenesis of autoimmune diseases. Br J Rheumatol 1997;36:1144–50.
   PubMedGoogle Scholar
• Griem P, Panthel K, Kalbacher H, Gleichmann E. Alteration of a model antigen by Au(III) leads to T cell sensitization to cryptic peptides. Eur J Immunol 1996;26:279–87.
   Google Scholar
• Trollmo C, Meyer AL, Steere AC, Hafler DA, Huber BT. Molecular mimicry in Lyme arthritis demonstrated at the single cell level: LFA-1 alpha L is a partial agonist for outer surface protein A- reactive T cells. J Immunol 2001;166: 5286–91.
   Google Scholar
• Bachmaier K, Neu N, de la Maza LM, Pal S, Hessel A, Penninger JM. Chlamydia infections and heart disease linked through antigenic mimicry. Science 1999;283:1335–9.
   Google Scholar
• Zhao ZS, Granucci F, Yeh L, Schaffer PA, Cantor H. Mol-ecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 1998;279: 1344–7.
   Google Scholar
• Davies JM. Introduction: Epitope mimicry as a component cause of autoimmune disease. Cell Mol Life Sci 2000;57:523–6.
   Google Scholar
• Rose NR, Mackay IR. Molecular mimicry: a critical look at exemplary instances in human diseases. Cell Mol Life Sci 2000;57:542–51.
   PubMed Web of Science ®Google Scholar
• Liang B, Mamula MJ. Molecular mimicry and the role of B lymphocytes in the processing of autoantigens. Cell Mol Life Sci 2000;57:561–8.
   PubMedGoogle Scholar
• Farris AD, Keech CL, Gordon TP, McCluskey J. Epitope mimics and determinant spreading: pathways to auto-immunity. Cell Mol Life Sci 2000;57:569–78.
   PubMedGoogle Scholar
• Yuki N. Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barre syndrome. Cell Mol Life Sci 2000;57:527–33.
   PubMed Web of Science ®Google Scholar
• Kukreja A, Maclaren NK. Current cases in which epitope mimicry is considered as a component cause of autoimmune disease: immune-mediated (type 1) diabetes. Cell Mol Life Sci 2000;57:534–41.
   PubMedGoogle Scholar
• Lawson CM. Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis. Cell Mol Life Sci 2000;57:552–60.
   PubMedGoogle Scholar
• Tanaka A, Prindiville TP, Gish R, Solnick JV, Coppel RL, Keeffe EB, et al. Are infectious agents involved in primary biliary cirrhosis? A PCR approach. J Hepatol 1999;31:664–71.
   PubMed Web of Science ®Google Scholar
• Yeaman SJ, Fussey SP, Danner DJ, James OF, Mutimer DJ, Bassendine MF. Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet 1988;1:1067–70.
   PubMed Web of Science ®Google Scholar
• Fussey SP, Ali ST, Guest JR, James OF, Bassendine MF, Yeaman S J. Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoainide acetyltransferase (E2p): characterization of the main immunogenic region. Proc Natl Acad Sci USA 1990;87: 3987–91.
   Google Scholar
• Vilagut L, Vila J, Vinas O, Pares A, Gines A, Jimenez de Anta MT, et al. Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis. J Hepatol 1994;21:673–7.
   Google Scholar
• Vilagut L, Pares A, Vinas O, Vila J, Jimenez de Anta MT, Rodes J. Antibodies to mycobacterial 65-kD heat shock protein cross-react with the main mitochondrial antigens in patients with primary biliary cirrhosis. Eur J Clin Invest 1997; 27:667–72.
   Google Scholar
• Harada K, Tsuneyama K, Sudo Y, Masuda S, Nakanuma Y. Molecular identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary cirrhosis: is Propionibac-terium acnes involved in granuloma formation? Hepatology 2001;33: 530–6.
   Google Scholar
• Nilsson HO, Taneera J, Castedal M, Glatz E, Olsson R, Wadstrom T. Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol 2000;38:1072–6.
   PubMed Web of Science ®Google Scholar
• Jones DE, Palmer JM, Burt AD, Walker C, Robe A J, Kirby JA. Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex. Hepatology 2002;36:679–86.
   PubMedGoogle Scholar
• Krams SM, Surh CD, Coppel RL, Ansari A, Ruebner B, Gershwin ME. Immunization of experimental animals with dihydrolipoamide acetyltransferase, as a purified recombinant polypeptide, generates mitochondrial antibodies but not primary biliary cirrhosis. Hepatology 1989;9:411–6.
   PubMedGoogle Scholar
• Cowie RL. Silica-dust-exposed mine workers with sclero-derma (systemic sclerosis). Chest 1987;92:260–2.
   PubMed Web of Science ®Google Scholar
• Rodnan GP, Benedek TG, Medsger TA Jr, Cammarata R J. The association of progressive systemic sclerosis (sclero-derma) with coal miners' pneumoconiosis and other forms of silicosis. Ann Intern Med 1967;66:323–34.
   Google Scholar
• Mountz JD, Downs Minor MB, Turner R, Thomas MB, Richards F, Pisko E. Bleomycin-induced cutaneous toxicity in the rat: analysis of histopathology and ultrastructure com-pared with progressive systemic sclerosis (scleroderma). Br J Dermatol 1983;108:679–86.
   PubMed Web of Science ®Google Scholar
• Bourgeois P, Aeschlimann A. Drug-induced scleroderma. Baillieres Clin Rheumatol 1991;5:13–20.
   Google Scholar
• Yung RL, Quddus J, Chrisp CE, Johnson KJ, Richardson BC. Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J Immunol 1995;154: 3025–35.
   Google Scholar
• D'Cruz D. Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol Lett 2000; 112–113.
   Google Scholar
• Jungers P, Dougados M, Pelissier C, Kuttenn F, Tron F, Lesavre P, et al. Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum 1982;25:618–23.
   PubMed Web of Science ®Google Scholar
• Leiter EH. Multiple low-dose streptozotocin-induced hyper-glycemia and insulitis in C57BL mice: influence of inbred background, sex, and thymus. Proc Natl Acad Sci USA 1982; 79:630–4.
   PubMed Web of Science ®Google Scholar
• Herold KC, Montag AG, Fitch FW. Treatment with anti-T-lymphocyte antibodies prevents induction of insulitis in mice given multiple doses of streptozocin. Diabetes 1987;36: 796–801.
   Google Scholar
• Pelletier L, Pasquier R, Rossert J, Vial MC, Mandet C, Druet P. Autoreactive T cells in mercury-induced autoimmunity. Ability to induce the autoimmune disease. J Immunol 1988; 140:750–4.
   Google Scholar
• Medzhitov R, Janeway CA Jr. How does the immune system distinguish self from nonself? Semin Immunol 2000;12:185-8; discussion 257–344.
   Google Scholar
• Rose NR. Viral damage or 'molecular mimicry' - placing the blame on myocarditis. Nat Med 2000;6:631–2.
   Google Scholar
• Powell JJ, Van De Water J, Gershwin ME. Evidence for the Role of Environmental Agents in the Initiation or Progression of Autoimmune Conditions. Environ Health Perspect 1999; 107:667–72.
   PubMed Web of Science ®Google Scholar
• Rao T, Richardson B. Environmentally induced autoimmune diseases: potential mechanisms. Environ Health Perspect 1999; 107 Suppl 5:737–42.
   PubMed Web of Science ®Google Scholar
• Mamula MJ, Gee RJ, Elliott JI, Sette A, Southwood S, Jones PJ, et al. Isoaspartyl post-translational modification triggers autoimmune responses to self-proteins. J Biol Chem 1999;274: 22321–7.
   PubMed Web of Science ®Google Scholar
• Bustamante J, Lodge JK, Marcocci L, Tritschler HJ, Packer L, Rihn BH. Alpha-lipoic acid in liver metabolism and disease. Free Radic Biol Med 1998;24:1023–39.
   PubMed Web of Science ®Google Scholar
• Furst SM, Luedke D, Gandolfi A J. Kupffer cells from halothane-exposed guinea pigs carry trifluoroacetylated pro-tein adducts. Toxicology 1997;120:119–32.
   Google Scholar
• Njoku D, Laster MJ, Gong DH, Eger El 2nd, Reed GF, Martin desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury. Anesth Analg 1997;84:173–8.
   PubMed Web of Science ®Google Scholar
• Sinha A, Clatch RJ, Stuck G, Blumenthal SA, Patel SA. Isoflurane hepatotoxicity: a case report and review of the literature. Am J Gastroenterol 1996;91:2406–9.
   Google Scholar
• Kenna JG. Immunoallergic drug-induced hepatitis: lessons from halothane. J Hepatol 1997;26 Suppl 1:5–12.
   Google Scholar
• Eliasson E, Gardner I, Hume-Smith H, de Waziers I, Beaune P, Kenna JG. Interindividual variability in P450-dependent generation of neoantigens in halothane hepatitis. Chem Biol Interact 1998;116: 123–41.
   Google Scholar
• Bourdi M, Chen W, Peter RM, Martin JL, Buters JT, Nelson SD, et al. Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis. Chem Res Toxicol 1996; 9: 1159–66.
   Google Scholar
• Gut J, Christen U, Frey N, Koch V, Stoffler D. Molecular mimicry in halothane hepatitis: biochemical and structural characterization of lipoylated autoantigens. Toxicology 1995 97199–224.
   Google Scholar
• Sasaki M, Ansari A, Pumford N, van de Water J, Leung PS, Humphries KM, et al. Comparative immunoreactivity of anti-trifluoroacetyl (TFA) antibody and anti-lipoic acid antibody in primary biliary cirrhosis: searching for a mimic. J Autoimmun 2000;15:51–60.
   Google Scholar
• Leung PS, Coppel RL, Ansari A, Munoz S, Gershwin ME. Antimitochondrial antibodies in primary biliary cirrhosis. Semin Liver Dis 1997;17:61–9.
   PubMed Web of Science ®Google Scholar
• Koike K, Ishibashi H, Koike M. Immunoreactivity of porcine heart dihydrolipoamide acetyl- and succinyl-transferases (PDC-E2, OGDC-E2) with primary biliary cirrhosis sera: characterization of the autoantigenic region and effects of enzymatic delipoylation and relipoylation. Hepatology 1998; 27:1467–74.
   Google Scholar
• Steinman L. Absence of 'original antigenic sin' in autoimmu-nity provides an unforeseen platform for immune therapy. J Exp Med 1999;189:1021–4.
   PubMed Web of Science ®Google Scholar
• Lam KS. Determination of peptide substrate motifs for protein kinases using a 'one-bead one-compound' combina-torial library approach. Methods Mol Biol 1998;87:83–6.
   Google Scholar
• Long SA, Quan C, Van de Water J, Nantz MH, Kurth MJ, Barsky D, et al. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol 2001; 167:2956–63.
   Google Scholar
• Leung PS, Quan C, Park O, Van de Water J, Kurth MJ, Nantz MH, et al. Immunization with a xenobiotic 6-bromo-hexanoate bovine serum albumin conjugate induces antimito-chondrial antibodies. J Immunol 2003;170: 5326–32.
   Google Scholar